DI-UMONS : Dépôt institutionnel de l’université de Mons

Recherche transversale
(titres de publication, de périodique et noms de colloque inclus)
2019-08-01 - Article/Dans un journal avec peer-review - Anglais - 17 page(s)

Mwamba Pierrot T., Muindu Moke, Kasongo Mutshitshi, Mujinga Gaelle K., Zabakani Mbedi, Kasongo Joel K., Tshamba Musumba, Nkwanga Jean-Claude, Marini Roland, Duez Pierre , Kalonji N.J.B., "Substandard/falsification antibacterial agents: a systematic review of liquid chromatographic and spectrophotometric methods for their detection" in American Journal of Analytical Chemistry, 10, 348-365, doi: 10.4236/ajac.2019.108024

  • Edition : Scientific Research Publishing, Irvine (CA)
  • Codes CREF : Essais, contrôle médicaments (DI3453), Chimie analytique (DI1314), Sciences pharmaceutiques (DI3400)
  • Unités de recherche UMONS : Chimie thérapeutique et Pharmacognosie (M136)
  • Instituts UMONS : Institut des Sciences et Technologies de la Santé (Santé)
Texte intégral :

Abstract(s) :

(Anglais) Falsified antibacterial agents continue to pose serious public health problems around the world. They are notably responsible for resistance emergence in the treatment of infectious diseases that can lead to death. The aim of this study was to summarize the literature on the methods developed and validated to detect poor quality antibacterial agents in order to assess the impact of these available methods in the fighting against Counterfeit/substandard medicines. Thus, studies published in the time from January 2000 to July 2017, were accessible via Google Scholar and Pubmed and allowed to analyze 41 papers. The majority (30) of developed and validated methods concerned LC methods, 9 regarded UV/V is spectrophotometry and two studies simultaneously developed both methods. Antibacterial agents belonging to beta- lactams group were the most concerned by the methods developed and validated (39%), followed by quinolones (18%) and macrolides (12%). Regarding active ingredients, amoxicillin (12%) was the most concerned by the development and validation methods. In spite of several available methods to detect substandard drugs, antibacterial agents for which methods were developed and validated were the most concerned by worldwide detected non-conformities. The fight against this scourge should not be only limited by their detection, but it also requires an effective involvement of different actors notably: health authorities, international organizations, pharmaceutical industries etc.